NCT01512992.
Methods |
Study design: unknown centres, single‐blinded, parallel individual randomised controlled trial in Spain Duration: 12 weeks Setting: clinic, hospital |
Participants |
Population: 380 adults recruited from clinics/hospitals in Spain Baseline characteristics: unknown Inclusion criteria: ≥ 40 years of age, COPD exacerbation, willing to participate in study, able to use devices for study Exclusion criteria: participated in previous COPD home telehealth study |
Interventions | Measurements taken at baseline and at 3 months Treatment arms
|
Outcomes |
Primary outcomes: hospital re‐admissions Secondary outcomes: HQOL by SF‐36, FEV₁, CAT, HADS, mortality, time to first re‐admission, emergency department visits, length of stay for re‐admission, patient satisfaction |
Notes |
Funding: Catalan Agency for Health Information, Assessment, and Quality Other identifier:NCT01512992 |